Toulouse, France

University Paul Sabatier

www.univ-tlse3.fr
Toulouse, France

Paul Sabatier University is a French university, in the Academy of Toulouse.Founded in 1229, the University of Toulouse is one of the oldest in Europe. Today’s Toulouse III was named for Paul Sabatier, winner of the 1912 Nobel prize in chemistry, when it was established on the foundations of the old university in 1969. The Université Paul Sabatier , an educational leader in France’s Midi-Pyrénées region, offers a broad array of programs in the science, technology, health, and athletics. Wikipedia.


Time filter

Source Type

Patent
University Paul Sabatier, French National Center for Scientific Research, Toulouse 1 University Capitole, French Institute of Health and Medical Research | Date: 2015-06-16

The invention concerns an inhibitor of the expression of chemokine CCL7 or an inhibitor of the expression of the receptor CCR3 or an inhibitor of CCL7/CCR3 interaction for the use of same to prevent or treat the extension of prostate cancer outside the prostatic capsule in a subject. The invention also concerns a method for determining the degree of aggressiveness of a prostate cancer tumour in a subject suffering from prostate cancer, comprising a step of determining the concentration or level of expression of the receptor CCR3 in a sample of prostate tumour cells obtained from said subject.


Patent
University Paul Sabatier and French National Center for Scientific Research | Date: 2015-03-27

Providing Nuclear factor (erythroid-derived 2)-like 2 (NRF2)-activated genes products, e.g. SOD1 and CAT, in their use in the prognosis of an OPA1 gene- or OPA1 gene product-deficit-induced disease, or related complications, e.g. optic atrophy and optic neuropathy, in a biological sample selected from fibroblasts, epithelial cells, blood samples or a mixture thereof, of a patient affected or suspected to be affected by the disease.


Patent
University Paul Sabatier and French National Center for Scientific Research | Date: 2017-06-21

The present invention concerns ceramics having a modified surface with improved bioactivity, their process of preparation and their use for orthopedics, dentistry or reconstructive surgery, in particular for use as a bone filler.


Patent
University Paul Sabatier and French National Center for Scientific Research | Date: 2016-12-15

The present invention concerns ceramics having a modified surface with improved bioactivity, their process of preparation and their use for orthopedics, dentistry or reconstructive surgery, in particular for use as a bone filler.


Patent
University Paul Sabatier and French National Center for Scientific Research | Date: 2016-12-15

The present invention concerns composite biomaterials comprising ceramic and a biodegradable polymer gel, with improved bioactivity, their process of preparation and their use for orthopedics, dentistry or reconstructive surgery, in particular for use as a bone filler.


Patent
French National Center for Scientific Research and University Paul Sabatier | Date: 2017-06-21

The method comprises:- placing a fluid guide forming composition (30) in contact with the optical source (12) and with the optical fiber (14),- injecting a first light in the guide forming composition (30) from the optical source (12) and/or from the optical fiber (14), to harden a central region of the optical guide,- illuminating the guide forming composition (30) with the second light to harden a peripheral region of the optical guide by photopolymerization initiated by the second photoinitiator system. The difference between the first peak wavelength and the second peak wavelength being more than 100 nm.


Patent
University Paul Sabatier and French National Center for Scientific Research | Date: 2017-06-21

The present invention concerns composite biomaterials comprising ceramic and a biodegradable polymer gel, with improved bioactivity, their process of preparation and their use for orthopedics, dentistry or reconstructive surgery, in particular for use as a bone filler.


Patent
University Paul Sabatier and French National Center for Scientific Research | Date: 2017-06-21

The present invention concerns ceramics having a modified surface with improved bioactivity, their process of preparation and their use for orthopedics, dentistry or reconstructive surgery, in particular for use as a bone filler.


Patent
University Paul Sabatier and French National Center for Scientific Research | Date: 2017-06-28

The present invention concerns composite biomaterials comprising ceramic and a biodegradable polymer gel, with improved bioactivity, their process of preparation and their use for orthopedics, dentistry or reconstructive surgery, in particular for use as a bone filler.


Patent
University Paul Sabatier and French National Center for Scientific Research | Date: 2017-02-01

The present invention provides the use of the activity or expression level of Nuclear factor (erythroid -derived 2)-like 2 (NRF2)-activated genes products, e.g. SOD1 and CAT, in the prognosis of an OPA1 gene- or OPA1 gene product- deficit-induced disease, e.g. optic atrophy and optic neuropathy, or related complications by detecting expression or activity in a biological sample selected from fibroblasts, epithelial cells, blood samples or a mixture thereof, of a patient affected or suspected to be affected by said disease.

Loading University Paul Sabatier collaborators
Loading University Paul Sabatier collaborators